A central focus of the partnership is equipping family physicians and other healthcare professionals to better identify and support individuals at risk.
Beyond the initial payment, Centessa shareholders are set to receive an extra USD9 per share in contingent value rights (CVR), which could increase the total deal value by USD1.5 billion.
Central to this deal is TSND-201, also known as methylone, Transcend’s lead experimental drug for post-traumatic stress disorder (PTSD) and other psychiatric conditions.
Falls represent one of the most serious health threats facing older adults, yet Mayo Clinic scientists have found that warning signs may already be visible in imaging tests that people undergo for entirely different reasons.
The hospital represents an investment of USD287 million, positioning it as one of the most substantial healthcare initiatives in the country.
This strategy recognizes that human health, animal health, and environmental health are interconnected and requires action across all three sectors.
The facility will include hospitals with a total of 500 beds, a medical faculty designed to educate approximately 5,000 students, and a dedicated research and training centre.
Hellmann’s new Dubai South location responds directly to these mounting pressures by offering comprehensive capabilities designed to meet the sector’s most demanding standards.
The partnership gives Ajman University students access to three major healthcare facilities: Sheikh Khalifa General Hospital in Umm Al Quwain, Sheikh Khalifa Specialty Hospital in Ras Al Khaimah, and Sheikh Khalifa Medical City in Ajman.
The acquisition grants Biogen access to two already-marketed medications that generated USD689 million in sales last year.